Drug Safety and AD/HD
http://thedianerehmshow.org/shows/2006-02-16/drug-safety-and-adhd
A scientific advisory panel voted 8 to 7 to recommend that the strongest possible safety warning be added to the labeling for certain drugs used to treat attention-deficit/hyperactivity disorder. A panel talks about what's behind this recommendation and how these drugs are being used and abused.
Guests
Dr. Steven Nissen
cardiologist at the Cleveland Clinic and a member of the FDA advisory panel that voted to recommend the strongest possible safety warning on certain drugs used to treat AD/HD
Dr. Jay Salpekar
director of outpatient psychiatry services at Children's National Medical Center
Dr. Lawrence H. Diller
behavioral developmental pediatrician practicing in Walnut Creek, Ca. and a member of the clinical faculty at the University of California--San Francisco. Author of "Running on Ritalin."
Lew Mills
psychotherapist in private practice in San Francisco who is taking medication for AD/HD, as are his two children
Please familiarize yourself with our Code of Conduct and Terms of Use before posting your comments.
